Satoko Nakano

Dr. Satoko Nakano

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2016 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CKChiea Chuen Khor
Chiea Chuen Khor
TDTan Do
Tan Do
HJHongyan Jia
Hongyan Jia
MNMasakazu Nakano
Masakazu Nakano
RGRonnie George
Ronnie George
TATin Aung
Tin Aung

29 May 2017 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
TATin Aung
Tin Aung
MOMineo Ozaki
Mineo Ozaki
MLMei Chin Lee
Mei Chin Lee
USUrsula Schlötzer-Schrehardt
Ursula Schlötzer-Schrehardt
GTGudmar Thorleifsson
Gudmar Thorleifsson
CKChiea Chuen Khor
Chiea Chuen Khor

23 February 2015 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
TATin Aung
Tin Aung
MOMineo Ozaki
Mineo Ozaki
TMTakanori Mizoguchi
Takanori Mizoguchi
RAR Rand Allingham
R Rand Allingham
ZLZheng Li
Zheng Li
CKChiea-Chuen Khor
Chiea-Chuen Khor

25 August 2015 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
MHMichael A. Hauser
Michael A. Hauser
IAInas F. Aboobakar
Inas F. Aboobakar
YLYutao Liu
Yutao Liu
SMShiroh Miura
Shiroh Miura
BWBenjamin T. Whigham
Benjamin T. Whigham
RAR. Rand Allingham
R. Rand Allingham
Exfoliation syndrome (XFS) is a common, age-related, systemic fibrillinopathy. It greatly increases risk of exfoliation glaucoma (XFG), a major worldwide cause of irreversible blindness. Coding variants in the lysyl oxidase-like 1 (LOXL1) gene are strongly associated with XFS in all studied populations, but a functional role for these variants has not been established. To identify additional candidate functional variants, we sequenced the entire LOXL1 genomic locus (∼40 kb) in 50 indigenous, black South African XFS cases and 50 matched controls. The variants with the strongest evidence of association were located in a well-defined 7-kb region bounded by the 3'-end of exon 1 and the adjacent region of intron 1 of LOXL1. We replicated this finding in US Caucasian (91 cases/1031 controls), German (771 cases/1365 controls) and Japanese (1484 cases/1188 controls) populations. The region of peak association lies upstream of LOXL1-AS1, a long non-coding RNA (lncRNA) encoded on the opposite strand of LOXL1. We show that this region contains a promoter and, importantly, that the strongly associated XFS risk alleles in the South African population are functional variants that significantly modulate the activity of this promoter. LOXL1-AS1 expression is also significantly altered in response to oxidative stress in human lens epithelial cells and in response to cyclic mechanical stress in human Schlemm's canal endothelial cells. Taken together, these findings support a functional role for the LOXL1-AS1 lncRNA in cellular stress response and suggest that dysregulation of its expression by genetic risk variants plays a key role in XFS pathogenesis.

1 July 2021 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
YTYukiko Terada
Yukiko Terada
TKToshikatsu Kaburaki
Toshikatsu Kaburaki
HTHiroshi Takase
Hiroshi Takase
HGHiroshi Goto
Hiroshi Goto
SNSatoko Nakano
Satoko Nakano
MMManabu Mochizuki
Manabu Mochizuki

23 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
FPFrancesca Pasutto
Francesca Pasutto
MZMatthias Zenkel
Matthias Zenkel
UHUrsula Hoja
Ursula Hoja
DBDaniel Berner
Daniel Berner
SUSteffen Uebe
Steffen Uebe
Ursula Schlötzer-SchrehardtUrsula Schlötzer-Schrehardt
Ursula Schlötzer-Schrehardt
Although lysyl oxidase-like 1 (LOXL1) is known as the principal genetic risk factor for pseudoexfoliation (PEX) syndrome, a major cause of glaucoma and cardiovascular complications, no functional variants have been identified to date. Here, we conduct a genome-wide association scan on 771 German PEX patients and 1,350 controls, followed by independent testing of associated variants in Italian and Japanese data sets. We focus on a 3.5-kb four-component polymorphic locus positioned spanning introns 1 and 2 of LOXL1 with enhancer-like chromatin features. We find that the rs11638944:C>G transversion exerts a cis-acting effect on the expression levels of LOXL1, mediated by differential binding of the transcription factor RXRα (retinoid X receptor alpha) and by modulating alternative splicing of LOXL1, eventually leading to reduced levels of LOXL1 mRNA in cells and tissues of risk allele carriers. These findings uncover a functional mechanism by which common noncoding variants influence LOXL1 expression.